Special Issue on “Recovery of Biological Products: Past, Present, Future”
Biotechnology and Bioengineering · 2024
DOI: 10.1002/bit.28792 ↗At a glance
Editorial in Biotechnology and Bioengineering, 2024. Written by Suzanne S Farid and 2 co-authors. Institution: Department of Biochemical Engineering, University College London (UCL), London, UK. Major MEDLINE topics: Biological Products. 24 references.
Abstract (original language)
Downstream processing is pivotal in the biotherapeutic production sector, which has evolved from traditional recombinant proteins to cutting-edge modalities such as novel engineered antibody formats and gene therapies.The recent pandemic has further diversified pipelines, with a significant increase in research and development for groundbreaking viral-vectored and RNA products.This evolution introduces unique purification challenges, underscoring the need for manufacturing approaches that are more flexible, agile, scalable, digitally integrated, supply chain resilient, and capable of faster market delivery.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Biochemical Engineering, University College London (UCL), London, UK.
- Global CMC Development, Mammalian Platform, Sanofi, Framingham, Massachusetts, USA.
- Development Product Portfolio, Novo Nordisk, Bagsværd, Denmark.
ORCID profiles: Suzanne S Farid, Arne Staby
Cite
APA
Farid, S. S., Tugcu, N., & Staby, A. (2024). Special Issue on “Recovery of Biological Products: Past, Present, Future”. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.28792
Vancouver
Farid SS, Tugcu N, Staby A. Special Issue on “Recovery of Biological Products: Past, Present, Future”. Biotechnology and Bioengineering. 2024. doi:10.1002/bit.28792
BibTeX
@article{Farid2024,
author = {Farid, Suzanne S and Tugcu, Nihal and Staby, Arne},
title = {Special Issue on “Recovery of Biological Products: Past, Present, Future”},
journal = {Biotechnology and Bioengineering},
year = {2024},
doi = {10.1002/bit.28792}
}
EUVIMED